| New Therapeutic Strategies for Systemic Sclerosis—a Critical Analysis of the Literature | |
Abstract/OtherAbstract
:
|
Systemic sclerosis (SSc) is a multi-system disease characterized by skin fibrosis and visceral disease. Therapy is organ and pathogenesis targeted. In this review, we describe novel strategies in the treatment of SSc. Utilizing the MEDLINE and the COCHRANE REGISTRY, we identified open trials, controlled trials, for treatment of SSc from 1999 to April 2005. We used the terms scleroderma, systemic sclerosis, Raynaud's phenomenon, pulmonary hypertension, methotrexate, cyclosporin, tacrolimus, relaxin, low-dose penicillamine, IVIg, calcium channel blockers, losartan, prazocin, iloprost, N-acetylcysteine, bosentan, cyclophosphamide, lung transplantation, ACE inhibitors, anti-thymocyte globulin, and stem cell transplantation. Anecdotal reports were omitted. |
Authors
:
|
Gisele Zandman-Goddard, Nurit Tweezer-Zaks, Yehuda Shoenfeld |
Related Documents
:
|
0029491818 - Improvement of pancreatic islet cell isolation for transplantation 0009560798 - Functional integration of transplanted purkinje cells into the atrophic cerebellum: ii.... |
Contributors
:
|
- |
Publication Detail
:
|
Publisher : Hindawi Publishing Corporation Type : - Format : - |
Date Detail
:
|
2005 |
Subject
:
|
- |
Coverage
:
|
- |
Relation
:
|
- |
Source
:
|
Clinical and Developmental Immunology |
Copyright Information
:
|
- |
Other Details
:
|
Languages : eng |
Export Citation
:
|
APA/MLA Format Download EndNote Download BibTex |
Previous Document: Crohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with Inflixim...
Next Document: Why Do People Die of Anaphylaxis?—A Clinical Review